Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing ioversol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ioversol 160mg[I]/mL injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 240mg[I]/mL injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 300mg[I]/mL injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 320mg[I]/mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 350mg[I]/mL injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 240mg[I]/mL injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 300mg[I]/mL injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 350mg[I]/mL prefilled syringe (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 320mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 240mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 160mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 300mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 350mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 300mg/mL (64%) injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 320mg/mL (68%) injection solution 75mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 320mg/mL (68%) injection solution 150mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 300mg/mL (64%) injection solution 200mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 160mg/mL (34%) injection solution 100mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 300mg/mL (64%) injection solution 150mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 240mg/mL (51%) injection solution 125mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 320mg/mL (68%) injection solution 200mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 350mg/mL (74%) injection solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 350mg/mL (74%) injection solution 50mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 240mg/mL (51%) injection solution100mL bag (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 300mg/mL (64%) injection solution 100mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 320mg/mL (68%) injection solution 30mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 320mg/mL (68%) injection solution 50mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 240mg/mL (51%) injection solution 200mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 320mg/mL (68%) injection solution 100mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 240mg/mL (51%) injection solution 150mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 350mg/mL (74%) injection solution 125mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 350mg/mL (74%) injection solution 150mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 350mg/mL (74%) injection solution 250mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 350mg/mL (74%) injection solution 30mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 320mg/mL (68%) injection solution 125mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 240mg/mL (51%) injection solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 160mg/mL (34%) injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 320mg/mL (68%) injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 240mg/mL (51%) injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 350mg/mL (74%) injection solution 100mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 350mg/mL (74%) injection solution 200mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 240mg[I]/mL injection solution 50 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 240mg[I]/mL injection solution 100 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 300mg[I]/mL injection solution 10 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 300mg[I]/mL injection solution 20 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 300mg[I]/mL injection solution 50 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 300mg[I]/mL injection solution 75 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 300mg[I]/mL injection solution 100 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 300mg[I]/mL injection solution 150 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 320mg[I]/mL injection solution 20 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 320mg[I]/mL injection solution 50 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 320mg[I]/mL injection solution 75 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 320mg[I]/mL injection solution 100 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 320mg[I]/mL injection solution 200 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 350mg[I]/mL injection solution 30 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 350mg[I]/mL injection solution 50 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 350mg[I]/mL injection solution 100 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 350mg[I]/mL injection solution 200 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 240mg[I]/mL injection solution 50 mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 300mg[I]/mL injection solution 50 mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 300mg[I]/mL injection solution 100 mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol 300mg[I]/mL injection solution 125 mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ioversol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ioversol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |